Ptc Drug Patent Portfolio
Ptc owns 1 orange book drug protected by 4 US patents Given below is the list of Ptc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12257252 | Compositions And Methods For Increasing Tetrahydrobiopterin Plasma Exposure | 06 Mar, 2042 | Active |
| US11752154 | Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof | 04 Sep, 2038 | Active |
| US12213982 | Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof | 04 Sep, 2038 | Active |
| US11072614 | Polymorphs Of Sepiapterin And Salts Thereof | 16 Apr, 2038 | Active |
Latest Legal Activities on Ptc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ptc.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Email Notification | 17 Sep, 2025 | US12257252 |
| Patent eCofC Notification | 16 Sep, 2025 | US12257252 |
| Recordation of Patent eCertificate of Correction | 16 Sep, 2025 | US12257252 |
| Mail Patent eCofC Notification | 16 Sep, 2025 | US12257252 |
| Post Issue Communication - Certificate of Correction | 21 Aug, 2025 | US12257252 |
| Email Notification | 27 May, 2025 | US12213982 |
| Mail O.P. Petition Decision | 27 May, 2025 | US12213982 |
| Mail-Petition Decision - Dismissed | 23 May, 2025 | US12213982 |
| Petition Decision - Dismissed | 22 May, 2025 | US12213982 |
| O.P. Petition Decision | 21 May, 2025 | US12213982 |
| RX - Mail Miscellaneous Communication to Applicant | 16 May, 2025 | US12213982 |
| Information Disclosure Statement considered | 15 May, 2025 | US12213982 |
| Patent eGrant Notification | 25 Mar, 2025 | US12257252 |
| Email Notification | 25 Mar, 2025 | US12257252 |
| Mail Patent eGrant Notification | 25 Mar, 2025 | US12257252 |
Ptc's Family Patents
Ptc Drug List
Given below is the complete list of Ptc's drugs and the patents protecting them.
1. Sephience
Sephience is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12257252 | Compositions And Methods For Increasing Tetrahydrobiopterin Plasma Exposure |
06 Mar, 2042
(15 years from now)
| Active |
| US11752154 | Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof |
04 Sep, 2038
(12 years from now)
| Active |
| US12213982 | Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof |
04 Sep, 2038
(12 years from now)
| Active |
| US11072614 | Polymorphs Of Sepiapterin And Salts Thereof |
16 Apr, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sephience's drug page